Financials
- Market Capitalization 2.36 B
- Employee 357
- Founded 2009
- CEO N/A
- Website www.nurixtx.com
- Headquarter Delaware, United States
- FIGI BBG00SDJ8M78
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1865 | VCEL Vericel Corporation - Common Stock | 47.49 USD | +1.04% | +0.87% | +25.40% | +30.65% | 2.43 B USD | ||
| 1872 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 40.55 USD | -1.65% | +2.35% | +36.58% | -6.55% | 2.41 B USD | ||
| 1887 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 12.62 USD | -1.10% | -9.21% | +59.75% | +540.61% | 2.35 B USD | ||
| 1888 | TRVI Trevi Therapeutics, Inc. - Common Stock | 16.52 USD | -7.40% | -8.63% | +14.64% | +134.99% | 2.35 B USD |
Frequently asked questions about Nurix Therapeutics, Inc. - Common stock
What is the Nurix Therapeutics, Inc. - Common stock stock price today?
The current price of Nurix Therapeutics, Inc. - Common stock (NRIX) is 22.71. Over the past 24 hours, the stock has changed by -1.52%. Follow the NRIX chart for real-time price dynamics.
What is the stock ticker of Nurix Therapeutics, Inc. - Common stock?
Nurix Therapeutics, Inc. - Common stock trades under the ticker NRIX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Nurix Therapeutics, Inc. - Common stock stock going up?
NRIX has changed by -5.65% over the last week, +32.81% over the last month, and +102.59% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Nurix Therapeutics, Inc. - Common stock net income for the last quarter?
Nurix Therapeutics, Inc. - Common stock reported net income of -89.53 M for the last quarter. The previous quarter showed -87.17 M, which means net income changed by -2.71%.
How many employees does Nurix Therapeutics, Inc. - Common stock have?
As of the latest available data, Nurix Therapeutics, Inc. - Common stock has 357 employees. Workforce size can provide additional context about the company's scale and operations.
What is Nurix Therapeutics, Inc. - Common stock EBITDA?
Nurix Therapeutics, Inc. - Common stock EBITDA is -95.76 M, and its EBITDA margin is -1 058.95%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Nurix Therapeutics, Inc. - Common stock stock?
You can buy Nurix Therapeutics, Inc. - Common stock (NRIX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Nurix Therapeutics, Inc. - Common stock stock?
Investing in Nurix Therapeutics, Inc. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NRIX chart and related analysis on metatrader.com as part of your research.